16 results on '"R. Schnaubelt"'
Search Results
2. Protocol for a Case-Control Study to Investigate the Association of Pellagra With Isoniazid Exposure During Tuberculosis Preventive Treatment Scale-Up in Malawi
- Author
-
Scott A. Nabity, Kelvin Mponda, Steve Gutreuter, Diya Surie, Anne Williams, Andrea J. Sharma, Elizabeth R. Schnaubelt, Rebekah E. Marshall, Hannah L. Kirking, Suzgo B. Zimba, Joram L. Sunguti, Laphiod Chisuwo, Mabvuto J. Chiwaula, Jesse F. Gregory, Robin da Silva, Michael Odo, Andreas Jahn, Thokozani Kalua, Rose Nyirenda, Belaineh Girma, James Mpunga, Nicole Buono, Alice Maida, Evelyn J. Kim, Laurence J. Gunde, Tigest F. Mekonnen, Andrew F. Auld, Adamson S. Muula, and John E. Oeltmann
- Subjects
isoniazid ,tuberculosis preventive treatment ,tuberulosis ,human immuno defficiency virus (HIV) ,pellagra ,niacin (nicotinic acid) ,Public aspects of medicine ,RA1-1270 - Abstract
Background: Pellagra is caused by niacin (vitamin B3) deficiency and manifested by a distinctive dermatitis. Isoniazid is critical for treating tuberculosis globally and is a component of most regimens to prevent tuberculosis. Isoniazid may contribute to pellagra by disrupting intracellular niacin synthesis. In 2017, Malawian clinicians recognized a high incidence of pellagra-like rashes after scale-up of isoniazid preventive treatment (IPT) to people living with HIV (PLHIV). This increase in pellagra incidence among PLHIV coincided with a seasonal period of sustained food insecurity in the region, which obscured epidemiological interpretations. Although isoniazid has been implicated as a secondary cause of pellagra for decades, no hypothesis-driven epidemiological study has assessed this relationship in a population exposed to isoniazid. We developed this case-control protocol to assess the association between large-scale isoniazid distribution and pellagra in Malawi.Methods: We measure the relative odds of having pellagra among isoniazid-exposed people compared to those without exposure while controlling for other pellagra risk factors. Secondary aims include measuring time from isoniazid initiation to onset of dermatitis, comparing niacin metabolites 1-methylnicotinamide (1-MN), and l-methyl-2-pyridone-5-carboxamide (2-PYR) in urine as a proxy for total body niacin status among subpopulations, and describing clinical outcomes after 30-days multi-B vitamin (containing 300 mg nicotinamide daily) therapy and isoniazid cessation (if exposed). We aim to enroll 197 participants with pellagra and 788 age- and sex-matched controls (1:4 ratio) presenting at three dermatology clinics. Four randomly selected community clinics within 3–25 km of designated dermatology clinics will refer persons with pellagra-like symptoms to one of the study enrollment sites for diagnosis. Trained study dermatologists will conduct a detailed exposure questionnaire and perform anthropometric measurements. A subset of enrollees will provide a casual urine specimen for niacin metabolites quantification and/or point-of-care isoniazid detection to confirm whether participants recently ingested isoniazid. We will use conditional logistic regression, matching age and sex, to estimate odds ratios for the primary study aim.Discussion: The results of this study will inform the programmatic scale-up of isoniazid-containing regimens to prevent tuberculosis.
- Published
- 2020
- Full Text
- View/download PDF
3. Long-Term Assessment of the Effects of COVID-19 and Isolation Care on Survivor Disability and Anxiety
- Author
-
Elizabeth R. Schnaubelt, Michael C. Wadman, Christopher J. Kratochvil, David M. Brett-Major, David S. Cates, M. Jana Broadhurst, Angela L. Hewlett, Daniel W. Johnson, James V. Lawler, and Chad Vokoun
- Subjects
Adult ,medicine.medical_specialty ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,Isolation (health care) ,Anxiety ,Standard score ,Patient Isolation ,Virology ,Pandemic ,medicine ,Humans ,Disabled Persons ,Survivors ,Psychiatry ,Aged ,SARS-CoV-2 ,business.industry ,COVID-19 ,Articles ,Middle Aged ,University hospital ,Infectious Diseases ,Cohort ,Parasitology ,medicine.symptom ,business - Abstract
We conducted an assessment of disability, anxiety, and other life impacts of COVID-19 and isolation care in a unique cohort of individuals. These included both community admissions to a university hospital as well as some of the earliest international aeromedical evacuees. Among an initial 16 COVID-19 survivors that were interviewed 6–12 months following their admission into isolation care, perception of their isolation care experience was related to their reporting of long-term consequences. However, anxiety and disability assessed with standard scores had no relationship with each other. Both capture of the isolation care experience and caution relying on single scoring systems for assessing long-term consequences in survivors are important considerations for on-going and future COVID-19 and other pandemic survivor research.
- Published
- 2021
- Full Text
- View/download PDF
4. Advanced Preparation Makes Research in Emergencies and Isolation Care Possible: The Case of Novel Coronavirus Disease (COVID-19)
- Author
-
Sharon Medcalf, M. Jana Broadhurst, Lu Ann Larson, Deborah A. Levy, Angela Vasa, Michael C. Wadman, James N. Sullivan, John J. Lowe, Hannah M. Creager, David M. Brett-Major, Theodore J. Cieslak, Jacob M. Dahlke, Ali S. Khan, Elizabeth R. Schnaubelt, Keith Hansen, James V. Lawler, Abigail E. Lowe, Michelle Schwedhelm, Paul D. Fey, Angela L. Hewlett, Mark G. Kortepeter, Rachel E. Lookadoo, Andre C. Kalil, Bruce Geoffrey Gordon, Mark E. Rupp, James Linder, Daniel W. Johnson, and Christopher J. Kratochvil
- Subjects
Male ,Biomedical Research ,Isolation (health care) ,media_common.quotation_subject ,Pneumonia, Viral ,030231 tropical medicine ,Context (language use) ,Disease ,medicine.disease_cause ,Perspective Piece ,law.invention ,Patient Isolation ,Betacoronavirus ,03 medical and health sciences ,Good governance ,COVID-19 Testing ,0302 clinical medicine ,law ,Virology ,Pandemic ,medicine ,Humans ,Function (engineering) ,Pandemics ,Coronavirus ,media_common ,Clinical Laboratory Techniques ,SARS-CoV-2 ,COVID-19 ,medicine.disease ,Infectious Diseases ,Quarantine ,CLARITY ,Female ,Parasitology ,Medical emergency ,Business ,Emergencies ,Coronavirus Infections - Abstract
The optimal time to initiate research on emergencies is before they occur. However, timely initiation of high-quality research may launch during an emergency under the right conditions. These include an appropriate context, clarity in scientific aims, preexisting resources, strong operational and research structures that are facile, and good governance. Here, Nebraskan rapid research efforts early during the 2020 coronavirus disease pandemic, while participating in the first use of U.S. federal quarantine in 50 years, are described from these aspects, as the global experience with this severe emerging infection grew apace. The experience has lessons in purpose, structure, function, and performance of research in any emergency, when facing any threat.
- Published
- 2020
- Full Text
- View/download PDF
5. Author Correction: Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care
- Author
-
Kevin K. Crown, John J. Lowe, Hannah M. Creager, Vicki L. Herrera, Danielle N Rivera, M. Jane Morwitzer, David M. Brett-Major, St Patrick Reid, Joshua L. Santarpia, James V. Lawler, Elizabeth R. Schnaubelt, M. Jana Broadhurst, and George W. Santarpia
- Subjects
2019-20 coronavirus outbreak ,Multidisciplinary ,Isolation (health care) ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,lcsh:R ,lcsh:Medicine ,Contamination ,Virology ,Aerosol ,law.invention ,law ,Quarantine ,Medicine ,lcsh:Q ,business ,lcsh:Science - Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- Published
- 2020
- Full Text
- View/download PDF
6. Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care
- Author
-
St Patrick Reid, James V. Lawler, M. Jane Morwitzer, John J. Lowe, Hannah M. Creager, Danielle N Rivera, Elizabeth R. Schnaubelt, M. Jana Broadhurst, George W. Santarpia, Kevin K. Crown, Vicki L. Herrera, Joshua L. Santarpia, and David M. Brett-Major
- Subjects
Time Factors ,Isolation (health care) ,Pneumonia, Viral ,lcsh:Medicine ,Diseases ,010501 environmental sciences ,medicine.disease_cause ,01 natural sciences ,Article ,law.invention ,03 medical and health sciences ,Betacoronavirus ,0302 clinical medicine ,law ,Environmental health ,Quarantine ,Pandemic ,Medicine ,Infection control ,Humans ,030212 general & internal medicine ,Viral shedding ,lcsh:Science ,Author Correction ,Pandemics ,0105 earth and related environmental sciences ,Coronavirus ,Aerosols ,Air Pollutants ,Infection Control ,Multidisciplinary ,business.industry ,Transmission (medicine) ,Reverse Transcriptase Polymerase Chain Reaction ,SARS-CoV-2 ,lcsh:R ,COVID-19 ,Transmission-based precautions ,Viral infection ,Infectious diseases ,RNA, Viral ,lcsh:Q ,Public Health ,business ,Coronavirus Infections - Abstract
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in Wuhan, China in late 2019, and its resulting coronavirus disease, COVID-19, was declared a pandemic by the World Health Organization on March 11, 2020. The rapid global spread of COVID-19 represents perhaps the most significant public health emergency in a century. As the pandemic progressed, a continued paucity of evidence on routes of SARS-CoV-2 transmission has resulted in shifting infection prevention and control guidelines between classically-defined airborne and droplet precautions. During the initial isolation of 13 individuals with COVID-19 at the University of Nebraska Medical Center, we collected air and surface samples to examine viral shedding from isolated individuals. We detected viral contamination among all samples, supporting the use of airborne isolation precautions when caring for COVID-19 patients.
- Published
- 2020
- Full Text
- View/download PDF
7. Co-infection of COVID-19 and Influenza A in A Hemodialysis Patient: A Case Report
- Author
-
David Goldner, Rama Vunnam, Srinivas R. Vunnam, Chad Vokoun, Ran Jing, Elizabeth R. Schnaubelt, and Allison M. Cushman-Vokoun
- Subjects
Male ,medicine.medical_specialty ,Oseltamivir ,medicine.medical_treatment ,Influenza A ,030204 cardiovascular system & hematology ,medicine.disease_cause ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Renal Dialysis ,Internal medicine ,Influenza, Human ,Pandemic ,Case report ,medicine ,Humans ,lcsh:RC109-216 ,030212 general & internal medicine ,Pandemics ,Dialysis ,Coronavirus ,Coinfection ,SARS-CoV-2 ,business.industry ,High risk ,virus diseases ,COVID-19 ,Middle Aged ,medicine.disease ,Co-infection ,Hospitalization ,Diarrhea ,Pneumonia ,Infectious Diseases ,chemistry ,Influenza A virus ,Hemodialysis ,Vomiting ,Kidney Failure, Chronic ,medicine.symptom ,Tomography, X-Ray Computed ,business - Abstract
Background Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus that was first discovered in December 2019 in Wuhan, China. With the growing numbers of community spread cases worldwide, the World Health Organization (WHO) declared the COVID-19 outbreak as a pandemic on March 11, 2020. Like influenza viruses, SARS-CoV-2 is thought to be mainly transmitted by droplets and direct contact, and COVID-19 has a similar disease presentation to influenza. Here we present a case of influenza A and COVID-19 co-infection in a 60-year-old man with end-stage renal disease (ESRD) on hemodialysis. Case presentation A 60-year-old man with ESRD on hemodialysis presented for worsening cough, shortness of breath, and diarrhea. The patient first developed a mild fever (37.8 °C) during hemodialysis 3 days prior to presentation and has been experiencing worsening flu-like symptoms, including fever of up to 38.6 °C, non-productive cough, generalized abdominal pain, nausea, vomiting, and liquid green diarrhea. He lives alone at home with no known sick contacts and denies any recent travel or visits to healthcare facilities other than the local dialysis center. Rapid flu test was positive for influenza A. Procalcitonin was elevated at 5.21 ng/mL with a normal white blood cell (WBC) count. Computed tomography (CT) chest demonstrated multifocal areas of consolidation and extensive mediastinal and hilar adenopathy concerning for pneumonia. He was admitted to the biocontainment unit of Nebraska Medicine for concerns of possible COVID-19 and was started on oseltamivir for influenza and vancomycin/cefepime for the probable bacterial cause of his pneumonia and diarrhea. Gastrointestinal (GI) pathogen panel and Clostridioides difficile toxin assay were negative. On the second day of admission, initial nasopharyngeal swab came back positive for SARS-CoV-2 by real-time reverse-transcriptase polymerase chain reaction (RT-PCR). The patient received supportive care and resumed bedside hemodialysis in strict isolation, and eventually fully recovered from COVID-19. Conclusions We presented a case of co-infection of influenza and SARS-CoV-2 in a hemodialysis patient. The possibility of SARS-CoV-2 co-infection should not be overlooked even when other viruses including influenza can explain the clinical symptoms, especially in high-risk patients.
- Published
- 2020
- Full Text
- View/download PDF
8. Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of Nebraska Medical Center
- Author
-
Mara J. Broadhurst, Elizabeth R. Schnaubelt, Joshua L. Santarpia, Herrera, James V. Lawler, John J. Lowe, David M. Brett-Major, Hannah M. Creager, Danielle N Rivera, Morwitzer Mj, Kevin K. Crown, George W. Santarpia, and St Patrick Reid
- Subjects
Isolation (health care) ,business.industry ,Transmission (medicine) ,viruses ,medicine.disease_cause ,Airborne transmission ,Virology ,Transmission-based precautions ,Pandemic ,Medicine ,Infection control ,Viral shedding ,business ,Coronavirus - Abstract
Lack of evidence on SARS-CoV-2 transmission dynamics has led to shifting isolation guidelines between airborne and droplet isolation precautions. During the initial isolation of 13 individuals confirmed positive with COVID-19 infection, air and surface samples were collected in eleven isolation rooms to examine viral shedding from isolated individuals. While all individuals were confirmed positive for SARS-CoV-2, symptoms and viral shedding to the environment varied considerably. Many commonly used items, toilet facilities, and air samples had evidence of viral contamination, indicating that SARS-CoV-2 is shed to the environment as expired particles, during toileting, and through contact with fomites. Disease spread through both direct (droplet and person-to-person) as well as indirect contact (contaminated objects and airborne transmission) are indicated, supporting the use of airborne isolation precautions.One Sentence SummarySARS-CoV-2 is shed during respiration, toileting, and fomite contact, indicating that infection may occur in both direct and indirect contact.
- Published
- 2020
- Full Text
- View/download PDF
9. Clinical Research in the HLCC Setting
- Author
-
Elizabeth R. Schnaubelt and Colleen S. Kraft
- Subjects
medicine.medical_specialty ,Clinical research ,business.industry ,medicine ,Medical physics ,business - Published
- 2020
- Full Text
- View/download PDF
10. Management of Acute Diarrheal Illness During Deployment: A Deployment Health Guideline and Expert Panel Report
- Author
-
Elizabeth R. Schnaubelt, Mark S. Riddle, Timothy Burgess, Patrick Connor, Clinton K. Murray, Jamie Fraser, David R. Tribble, James D. Mancuso, Timothy P. Ballard, and Gregory J Martin
- Subjects
Diarrhea ,0301 basic medicine ,Warfare ,medicine.medical_specialty ,030231 tropical medicine ,030106 microbiology ,MEDLINE ,Guidelines as Topic ,Article ,Disease Outbreaks ,Military medicine ,03 medical and health sciences ,0302 clinical medicine ,Humans ,Medicine ,Disease management (health) ,Evidence-Based Medicine ,business.industry ,Public health ,Public Health, Environmental and Occupational Health ,Disease Management ,Dysentery ,General Medicine ,Guideline ,medicine.disease ,Critical appraisal ,Medical emergency ,medicine.symptom ,business - Abstract
Acute diarrheal illness during deployment causes significant morbidity and loss of duty days. Effective and timely treatment is needed to reduce individual, unit, and health system performance impacts.This critical appraisal of the literature, as part of the development of expert consensus guidelines, asked several key questions related to self-care and healthcare-seeking behavior, antibiotics for self-treatment of travelers' diarrhea, what antibiotics/regimens should be considered for treatment of acute watery diarrhea and febrile diarrhea and/or dysentery, and when and what laboratory diagnostics should be used to support management of deployment-related travelers' diarrhea. Studies of acute diarrhea management in military and other travelers were assessed for relevance and quality. On the basis of this critical appraisal, guideline recommendations were developed and graded by the Expert Panel using good standards in clinical guideline development methodology.New definitions for defining the severity of diarrhea during deployment were established. A total of 13 graded recommendations on the topics of prophylaxis, therapy and diagnosis, and follow-up were developed. In addition, four non-graded consensus-based statements were adopted.Successful management of acute diarrheal illness during deployment requires action at the provider, population, and commander levels. Strong evidence supports that single-dose antimicrobial therapy is effective in most cases of moderate to severe acute diarrheal illness during deployment. Further studies are needed to address gaps in available knowledge regarding optimal therapies for treatment, prevention, and laboratory testing of acute diarrheal illness.
- Published
- 2017
- Full Text
- View/download PDF
11. Loss to follow-up among patients receiving anti-tuberculosis treatment, Haiti, 2011-2015
- Author
-
J. P. Cegielski, Macarthur Charles, W. Morose, E. R. Schnaubelt, M. Richard, and David L. Fitter
- Subjects
0301 basic medicine ,Pediatrics ,medicine.medical_specialty ,Tuberculosis ,business.industry ,Health Policy ,030106 microbiology ,Hazard ratio ,Public Health, Environmental and Occupational Health ,Human immunodeficiency virus (HIV) ,Psychological intervention ,virus diseases ,Original Articles ,Logistic regression ,medicine.disease_cause ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,Anti tuberculosis ,Median time ,medicine ,030212 general & internal medicine ,business ,Survival analysis - Abstract
Setting: Tuberculosis (TB) treatment facilities in Haiti. Objective: To assess factors associated with loss to follow-up (LTFU) among patients receiving treatment for tuberculosis (TB) in Haiti. Design: We analyzed Haiti's national surveillance data for patients started on anti-tuberculosis treatment from 2011 to 2015 to determine factors associated with LTFU using multivariable logistic regression and describe LTFU in terms of subnational units to target future intervention strategies. We also conducted a survival analysis to estimate hazard ratios of factors associated with time to LTFU. Results: Of 81 490 TB cases reported, 7423 (9.1%) were LTFU during anti-tuberculosis treatment, increasing from 7.1% in 2011 to 10.3% in 2015. Six high-volume facilities had significantly higher rates of LTFU (14.3-31.9%) than the rest of the country, accounting for 18.8% of all TB cases reported, but 41.7% of all LTFU patients. Male sex, previous treatment history, and human immunodeficiency virus infection were associated with higher rates of LTFU. The median time to LTFU was 94 days. Conclusion: A small number of facilities accounted for disproportionately high rates of LTFU. These results identify characteristics of facilities and individuals leading to concentrated interventions to reduce LTFU and improve treatment success.
- Published
- 2018
12. One-dimensional degenerate operators in L^p-spaces
- Author
-
S. Fornaro, R. Schnaubelt, METAFUNE, Giorgio Gustavo Ermanno, PALLARA, Diego, S., Fornaro, Metafune, Giorgio Gustavo Ermanno, Pallara, Diego, and R., Schnaubelt
- Published
- 2013
13. The Spectral Mapping Theorem for Evlution Semigroups on Associated with Strongly Continuous Cocycles
- Author
-
Y. Latushkin and R. Schnaubelt
- Subjects
Combinatorics ,Metric space ,Algebra and Number Theory ,Picard–Lindelöf theorem ,Spectral mapping ,Banach space ,Closed graph theorem ,Locally compact space ,Open mapping theorem (functional analysis) ,Brouwer fixed-point theorem ,Mathematics - Abstract
(Theta,mu;X), 1≤p
- Published
- 1999
- Full Text
- View/download PDF
14. Two dual classes of time-varying well-posed linear systems constructed from passive systems
- Author
-
George Weiss and R. Schnaubelt
- Subjects
Algebra ,Well-posed problem ,symbols.namesake ,Partial differential equation ,Semigroup ,Product (mathematics) ,Mathematical analysis ,Linear system ,Hilbert space ,symbols ,State space ,Type (model theory) ,Mathematics - Abstract
We introduce two classes of well-posed linear time-varying (LTV) systems. Each of these can be constructed easily, starting from a time-invariant scattering-passive system, by introducing a time-dependent inner product on the state space and modifying some of the generating operators. These classes of LTV systems are motivated by physical examples, such as an electromagnetic field around a moving object. To prove the well-posedness of these LTV systems, we use the Lax-Phillips semigroup induced by a well-posed linear system, as in scattering theory. We modify this semigroup to obtain a Lax-Phillips type evolution family.
- Published
- 2006
- Full Text
- View/download PDF
15. Second order elliptic operators in L^2 with first order degeneration at the boundary and outward pointing drift
- Author
-
Roland Schnaubelt, Giorgio Metafune, Diego Pallara, Simona Fornaro, S., Fornaro, Metafune, Giorgio Gustavo Ermanno, Pallara, Diego, and R., Schnaubelt
- Subjects
Diffusion (acoustics) ,Elliptic operator ,Work (thermodynamics) ,Applied Mathematics ,Mathematical analysis ,Degenerate energy levels ,Boundary (topology) ,Order (ring theory) ,General Medicine ,Boundary value problem ,Analysis ,Domain (mathematical analysis) ,Mathematics - Abstract
We study second order elliptic operators whose diffusion coefficients degenerate at the boundary in first order and whose drift term strongly points outward. It is shown that these operators generate analytic semigroups in $L^2$ where they are equipped with their natural domain without boundary conditions. Hence, the corresponding parabolic problem can be solved with optimal regularity. In a previous work we had treated the case of inward pointing drift terms.
16. Acute and Long-Term Toxicity after Planned Intraoperative Boost and Whole Breast Irradiation in High-Risk Patients with Breast Cancer-Results from the Targeted Intraoperative Radiotherapy Boost Quality Registry (TARGIT BQR).
- Author
-
Goerdt L, Schnaubelt R, Kraus-Tiefenbacher U, Brück V, Bauer L, Dinges S, von der Assen A, Meye H, Kaiser C, Weiss C, Clausen S, Schneider F, Abo-Madyan Y, Fleckenstein K, Berlit S, Tuschy B, Sütterlin M, Wenz F, and Sperk E
- Abstract
In the context of breast cancer treatment optimization, this study prospectively examines the feasibility and outcomes of utilizing intraoperative radiotherapy (IORT) as a boost in combination with standard external beam radiotherapy (EBRT) for high-risk patients. Different guidelines recommend such a tumor bed boost in addition to whole breast irradiation with EBRT for patients with risk factors for local breast cancer recurrence. The TARGIT BQR (NCT01440010) is a prospective, multicenter registry study aimed at ensuring the quality of clinical outcomes. It provides, for the first time, data from a large cohort with a detailed assessment of acute and long-term toxicity following an IORT boost using low-energy X-rays. Inclusion criteria encompassed tumors up to 3.5 cm in size and preoperative indications for a boost. The IORT boost, administered immediately after tumor resection, delivered a single dose of 20 Gy. EBRT and systemic therapy adhered to local tumor board recommendations. Follow-up for toxicity assessment (LENT SOMA criteria: fibrosis, teleangiectasia, retraction, pain, breast edema, lymphedema, hyperpigmentation, ulceration) took place before surgery, 6 weeks to 90 days after EBRT, 6 months after IORT, and then annually using standardized case report forms (CRFs). Between 2011 and 2020, 1133 patients from 10 centers were preoperatively enrolled. The planned IORT boost was conducted in 90%, and EBRT in 97% of cases. Median follow-up was 32 months (range 1-120, 20.4% dropped out), with a median age of 61 years (range 30-90). No acute grade 3 or 4 toxicities were observed. Acute side effects included erythema grade 1 or 2 in 4.4%, palpable seroma in 9.1%, punctured seroma in 0.3%, and wound healing disorders in 2.1%. Overall, chronic teleangiectasia of any grade occurred in 16.2%, fibrosis grade ≥ 2 in 14.3%, pain grade ≥ 2 in 3.4%, and hyperpigmentation in 1.1%. In conclusion, a tumor bed boost through IORT using low-energy X-rays is a swift and feasible method that demonstrates low rates in terms of acute or long-term toxicity profiles in combination with whole breast irradiation.
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.